- Home
- / Sirnaomics
Sirnaomics
Stock Price
$3.2
2024-10-29
Market Capitalization
$253.5 M
2024-10-29
Sirnaomics Summary
Company Summary
- Overview
- Sirnaomics is a biopharmaceutical company that specializes in drug development solutions. It focuses on developing ribonucleic acid (RNA) based therapeutics for treating cancer, skin conditions, fibrosis-related diseases, and antiviral and cardiometabolic diseases.
- Type
- Public
- Status
- Active
- Founded
- 2007
- HQ
- Gaithersburg, MD, US | view all locations
- Website
- https://sirnaomics.com/
- Cybersecurity rating
Table of Contents
Key People
Francois Lebel, Chief Medical Officer
Edward Wang, Chief Production Officer, Executive Director
Richard W. Welch, Vice President, CMC
LocationsView all
5 locations detected
Gaithersburg, MD HQ
United States
20511 Seneca Meadows Parkway, Suite 200
Cambridge, MA
United States
245 First Street, 18F
Guangzhou, Guang Dong Sheng
China
12 Luoxuan 3 Road, STE 4-306, Guangzhou International Bio-island
Suzhou, Jiang Su Sheng
China
218 Xinghu Street, STE A4-415
Hong Kong, Hong Kong Island
Hong Kong
46/F, Hopewell Centre, 183 Queen's Road East